Increase the gap between two doses of Serum Institute of India’s Oxford Covid-19 vaccine ‘Covishield’ to 12-16 weeks, a government panel has recommended. Currently, the interval between two doses of Covishield is four to eight weeks. The recommended interval between the two doses of Covishield, manufactured by Pune’s Serum Institute of India, was increased from four-six weeks to six-eight weeks in April. No change in dosage interval for Covaxin was suggested by the panel.
The Central Government panel further recommended that pregnant women may be offered the choice to take any Covid-19 vaccine and that lactating women can be inoculated any time after delivery. The recommendations come amid several states reporting a shortage of vaccines. Several states and UTs including Delhi, Maharashtra, Karnataka, and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply falling short to meet the rising demand.
The Hyderabad-based Bharat Biotech’s indigenously developed Covaxin and Oxford-AstraZeneca’s Covishield are currently being used in India’s inoculation drive against coronavirus.